These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37743616)

  • 1. Pharmacological Effects of Cinobufagin.
    Zhang H; Jian B; Kuang H
    Med Sci Monit; 2023 Sep; 29():e940889. PubMed ID: 37743616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toad venom: A comprehensive review of chemical constituents, anticancer activities, and mechanisms.
    Li FJ; Hu JH; Ren X; Zhou CM; Liu Q; Zhang YQ
    Arch Pharm (Weinheim); 2021 Jul; 354(7):e2100060. PubMed ID: 33887066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinobufagin induces autophagy-mediated cell death in human osteosarcoma U2OS cells through the ROS/JNK/p38 signaling pathway.
    Ma K; Zhang C; Huang MY; Li WY; Hu GQ
    Oncol Rep; 2016 Jul; 36(1):90-8. PubMed ID: 27176794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of cytotoxic effect of the bufanolide steroid compound cinobufagin and its related underlying mechanism in brain cell models.
    Hsu SS; Lin YS; Liang WZ
    J Biochem Mol Toxicol; 2021 Oct; 35(10):e22862. PubMed ID: 34309954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new bufadienolide with cytotoxic activity from the Chinese traditional drug Ch'an Su.
    Xu R; Xie HQ; Deng LL; Zhang JX; Yang FM; Liu JH; Hao XJ; Zhang YH
    Chin J Nat Med; 2014 Aug; 12(8):623-7. PubMed ID: 25156289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uncovering the Mechanisms of Active Components from Toad Venom against Hepatocellular Carcinoma Using Untargeted Metabolomics.
    Liang P; Ma Y; Yang L; Mao L; Sun Q; Sun C; Liu Z; Mazhar M; Yang S; Ren W
    Molecules; 2022 Nov; 27(22):. PubMed ID: 36431859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical profiling and cytotoxicity assay of bufadienolides in toad venom and toad skin.
    Meng Q; Yau LF; Lu JG; Wu ZZ; Zhang BX; Wang JR; Jiang ZH
    J Ethnopharmacol; 2016 Jul; 187():74-82. PubMed ID: 27063985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Cinobufagin on Hepatocellular Carcinoma Cells Enhanced by MRT68921, an Autophagy Inhibitor.
    Xu Z; Bao J; Jin X; Li H; Fan K; Wu Z; Yao M; Zhang Y; Liu G; Wang D; Yu X; Guo J; Xu R; Gong Q; Wang F; Wang J
    Am J Chin Med; 2023; 51(6):1595-1611. PubMed ID: 37489112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinobufagin inhibits tumor progression and reduces doxorubicin resistance by enhancing FOXO1-mediated transcription of FCGBP in osteosarcoma.
    Ma X; Suo Z; Ma X; Zhan C; Luo G; Song J
    J Ethnopharmacol; 2022 Oct; 296():115433. PubMed ID: 35690338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Paraguayan Rhinella toad venom: Implications in the traditional medicine and proliferation of breast cancer cells.
    Schmeda-Hirschmann G; Gomez CV; Rojas de Arias A; Burgos-Edwards A; Alfonso J; Rolon M; Brusquetti F; Netto F; Urra FA; Cárdenas C
    J Ethnopharmacol; 2017 Mar; 199():106-118. PubMed ID: 28131913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced hyperkalemia.
    Pantanowitz L
    Am J Med; 2002 Mar; 112(4):334-5. PubMed ID: 11893385
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemical Composition, Pharmacological Effects and Clinical Applications of Cinobufacini.
    Zuo Q; Xu DQ; Yue SJ; Fu RJ; Tang YP
    Chin J Integr Med; 2024 Apr; 30(4):366-378. PubMed ID: 38212503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toad venom bufadienolides and bufotoxins: An updated review.
    Asrorov AM; Kayumov M; Mukhamedov N; Yashinov A; Mirakhmetova Z; Huang Y; Yili A; Aisa HA; Tashmukhamedov M; Salikhov S; Mirzaakhmedov S
    Drug Dev Res; 2023 Aug; 84(5):815-838. PubMed ID: 37154099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulatory effects of bufalin, an active ingredient from toad venom on voltage-gated sodium channels.
    Tao J; Jiang F; Liu C; Liu Z; Zhu Y; Xu J; Ge Y; Xu K; Yin P
    Mol Biol Rep; 2018 Oct; 45(5):721-740. PubMed ID: 29931533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of P-gp-mediated multidrug resistance in colon cancer by cinobufagin.
    Yuan Z; Shi X; Qiu Y; Jia T; Yuan X; Zou Y; Liu C; Yu H; Yuan Y; He X; Xu K; Yin P
    Oncol Rep; 2017 Mar; 37(3):1815-1825. PubMed ID: 28184922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative activity and new argininyl bufadienolide esters from the "cururú" toad Rhinella (Bufo) schneideri.
    Schmeda-Hirschmann G; Quispe C; Theoduloz C; de Sousa PT; Parizotto C
    J Ethnopharmacol; 2014 Sep; 155(2):1076-85. PubMed ID: 24945399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resibufogenin and cinobufagin activate central neurons through an ouabain-like action.
    Wang ZJ; Sun L; Heinbockel T
    PLoS One; 2014; 9(11):e113272. PubMed ID: 25420080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cinobufagin induces cell cycle arrest at the S phase and promotes apoptosis in nasopharyngeal carcinoma cells.
    Pan Z; Luo Y; Xia Y; Zhang X; Qin Y; Liu W; Li M; Liu X; Zheng Q; Li D
    Biomed Pharmacother; 2020 Feb; 122():109763. PubMed ID: 31918288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-tumor effects and 3D-quantitative structure-activity relationship analysis of bufadienolides from toad venom.
    Liu JS; Deng LJ; Tian HY; Ruan ZX; Cao HH; Ye WC; Zhang DM; Yu ZL
    Fitoterapia; 2019 Apr; 134():362-371. PubMed ID: 30872126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.